3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Nasopharyngeal Carcinoma
6
Colorectal Neoplasms
4
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Melanoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Esophageal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Radiation Injuries
1
Quality of Life
1
Osteosarcoma
1
Non-squamous Non-small Cell Lung Cancer
1
Neuroblastoma
1
Nasopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Brain Neoplasms
1
Advanced Pancreatic Cancer
1
Advanced Colorectal Cancer
1
Adenocarcinoma of Lung
1
Interventions
surufatinib
2
regorafenib
2
Oxaliplatin
2
Irinotecan
2
Fluorouracil
2
Drug Therapy
2
Bevacizumab
2
raltitrexed
1
nimotuzumab
1
endostar protein
1
aflibercept
1
Folfox protocol
1
Cetuximab
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Advanced Colorectal Cancer
×
endostar protein
×
Clear all
NCT00853684
2009-09-18
OXCE
Shanghai Jiao Tong University School of Medicine
Phase 2
Unknown
44 enrolled